Cardiology Policy

Roe v. Wade’s Cardiology Impact

The fall of Roe V. Wade garnered reactions from cardiologists across the country, many emphasizing the burden pregnancy places on the heart– literally– and how the Supreme Court’s decision may endanger patients.

Cardiovascular disease is the leading cause of pregnancy-related death in the US, making cardiologists a key part of at-risk pregnant patients’ care teams. Cardiologists may discuss these patients’ CV health risks, the risks to the fetus, and the relative safety of continuing the pregnancy versus undergoing pregnancy termination.

Now, state lawmakers have the power to restrict the scope of these discussions. While most state abortion bans provide exceptions for pregnancies threatening the mother’s life, experts say the definition of “lifesaving” is murky. 

  • Georgetown University law professor, Lawrence Gostin, explained how the vague language leaves cardiologists and other physicians’ criminal liability up in the air. “At best, it will make physicians hesitate to save the life of a woman; at worst, outright refuse to.”

The Consequences for cardiologists and other clinicians who breach abortion bans also vary widely by state, ranging from losing a medical license to life in prison.  

Cardiology societies widely criticized the SCOTUS ruling, citing concerns about the integrity of patient-physician relationships, including this statement by The American College of Cardiology:

“The College is deeply concerned about the potential implications of the Supreme Court decision regarding Roe v. Wade on the ability of patients and clinicians to engage in important shared discussions about maternal health, or to remove previously available health care options, especially given the alarming maternal health crisis in the U.S.”

​​The Takeaway

Cardiology leaders made it clear that the decision to overturn the landmark ruling will have downstream consequences for cardiologists. Exactly what those consequences will look like will vary by state, and are still shrouded in ambiguity.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Atrial Fibrillation November 10, 2025

ARREST-AF and the Importance of Lifestyle Post-Ablation November 10, 2025

Catheter ablation for atrial fibrillation might be missing half its potential, after results from the ARREST-AF trial demonstrated that structured lifestyle and risk factor management significantly increases a patient’s 12-month freedom from arrhythmia while cutting recurrence risk nearly in half. That could be changing now, thanks to the ARREST-AF trial which randomized 122 patients with […]

Heart Failure November 6, 2025

PREVENT-TAHA8 Supports Stem Cells for Post-MI HF November 6, 2025

Stem cell therapy for post-MI heart failure might deserve a second look, after the PREVENT-TAHA8 trial demonstrated that mesenchymal stem cell infusion within days of STEMI significantly reduced 3-year HF incidence. Based in Iran, the PREVENT-TAHA8 trial, randomized 396 patients following LAD STEMI with LVEF <40%, to receive either an intracoronary mesenchymal stem cell infusion […]

Structural Heart November 3, 2025

Abbott’s Tendyne TMVR System Works Even in the Sickest MR Patients November 3, 2025

New research presented at TCT 2025 suggests that Abbott’s FDA-approved Tendyne TMVR system leads to significantly better health outcomes in patients with severe mitral annular calcification who were previously considered untreatable. The SUMMIT-MAC trial enrolled 103 patients with severe MAC and found that the challenging patient population showed strong outcomes despite extreme pathology… However, patients […]

This content is exclusive to subscribers

Log in or join by entering your email below.

Completely free. Every Monday and Thursday.

CW Phone Square